Articles by Peter P. Toth (20)

A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the “Back of the Line” as a therapy for dyslipidemia?

Peter P. Toth and Kevin C. Maki

Journal of Clinical Lipidology 2 ( 5 ): 313 - 317 , 2008

Lipid therapy utilization rates in a managed-care mixed dyslipidemia population

Peter P. Toth, Victoria Zarotsky, Jane M. Sullivan and Dave Laitinen

Journal of Clinical Lipidology 2 ( 5 ): 365 - 374 , 2008

High-density lipoproteins: Marker of cardiovascular risk and therapeutic target

Peter P. Toth and Michael H. Davidson

Journal of Clinical Lipidology 4 ( 5 ): 359 - 364 , 2010

Activation of intracellular signaling systems by high-density lipoproteins

Peter P. Toth

Journal of Clinical Lipidology 4 ( 5 ): 376 - 381 , 2010

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Anne C. Goldberg, Paul N. Hopkins, Peter P. Toth, Christie M. Ballantyne, Daniel J. Rader, Jennifer G. Robinson, Stephen R. Daniels, Samuel S. Gidding, Sarah D. de Ferranti, Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty, William C. Cromwell, Joyce L. Ross and Paul E. Ziajka

Journal of Clinical Lipidology 5 ( 3 ): 133 - 140 , 2011

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W. Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki and Mary R. Dicklin

Journal of Clinical Lipidology 5 ( 5 ): 338 - 367 , 2011

Antisense therapy and emerging applications for the management of dyslipidemia

Peter P. Toth

Journal of Clinical Lipidology 5 ( 6 ): 441 - 449 , 2011

Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism

Matthew Konerman, Krishnaji Kulkarni, Peter P. Toth and Steven R. Jones

Journal of Clinical Lipidology 6 ( 1 ): 27 - 32 , 2012

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction

Peter P. Toth, Christie M. Ballantyne, Michael H. Davidson, Joanne E. Tomassini, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, X. Henry Hu and Kaan Tunceli

Journal of Clinical Lipidology 6 ( 2 ): 180 - 191 , 2012

Relative Effect of Fenofibrate and Equivalent Statin Therapies on the Attributable Costs of Macrovascular Complications Following Type II Diabetes

Robert J. Simko, Peter P. Toth, S. R. Palli and R. A. Quimbo

Journal of Clinical Lipidology 6 ( 3 ): 268 - 269 , 2012

Reduction in Estimated 10-Year Coronary Heart Disease Risk Using Reynolds Risk Score: A Post-Hoc Analysis of Exenatide-Treated Patients with Diabetes

Elaine Chiquette, Gilbert Ramirez, Peter P. Toth, Michael Cobble, Brandon Walsh and Robert Chilton

Journal of Clinical Lipidology 6 ( 3 ): 256 - 257 , 2012

Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006

Peter P. Toth, Danielle Potter and Eileen E. Ming

Journal of Clinical Lipidology 6 ( 4 ): 325 - 330 , 2012

Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association

Harold E. Bays, Peter P. Toth, Penny M. Kris-Etherton, Nicola Abate, Louis J. Aronne, W. Virgil Brown, J. Michael Gonzalez-Campoy, Steven R. Jones, Rekha Kumar, Ralph La Forge and Varman T. Samuel

Journal of Clinical Lipidology 7 ( 4 ): 304 - 383 , 2013

High-density lipoproteins: A consensus statement from the National Lipid Association

Peter P. Toth, Philip J. Barter, Robert S. Rosenson, William E. Boden, M. John Chapman and Marina Cuchel

Journal of Clinical Lipidology 7 ( 5 ): 484 - 525 , 2013

Polish Lipid Association - A strong response to the problem of lipid disorders in Poland and Central and Eastern Europe

Maciej Banach, Michael Davidson and Peter P. Toth

Journal of Clinical Lipidology 6 ( 2 ): 105 - 107 , 2012

Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups

Matthew Konerman, Krishnaji Kulkarni, Peter P. Toth and Steven R. Jones

Journal of Clinical Lipidology 6 ( 4 ): 368 - 373 , 2012

Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease

Peter P. Toth, JoAnne M. Foody, Joanne E. Tomassini, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu and Kaan Tunceli

Journal of Clinical Lipidology 8 ( 1 ): 107 - 116 , 2014

Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita and John J.P. Kastelein

Journal of Clinical Lipidology 8 ( 2 ): 148 - 172 , 2014

JCL Roundtable: HDL in the primary care setting

W. Virgil Brown, Benjamin J. Ansell, Rachel H. Mackey and Peter P. Toth

Journal of Clinical Lipidology 8 ( 4 ): 364 - 372 , 2014

Prevalence of dyslipidemia and associated risk factors in Turkish adults

Fahri Bayram, Derya Kocer, Kursat Gundogan, Ahmet Kaya, Ozgur Demir, Ramazan Coskun, Tevfik Sabuncu, Ahmet Karaman, Mustafa Cesur, Manfredi Rizzo, Peter P. Toth and Vedia Gedik

Journal of Clinical Lipidology 8 ( 2 ): 206 - 216 , 2014

Do you have a suggestion for journals

Suggest Journal